bromine has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, JB; Austin, CJ; Harris, HH; Jolliffe, KA; Rendina, LM; Sheridan, EJ; Vogt, S | 1 |
| Boudreau, C; Cai, SX; Custeau, D; Desputeau, C; Dong, K; Drewe, J; Geerts, L; Gourdeau, H; Hamelin, B; Kasibhatla, S; Kianicka, I; Labrecque, D; Leblond, L; Tseng, B | 1 |
2 other study(ies) available for bromine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells.
Topics: Animals; Bromine; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Oligopeptides; Peptides, Cyclic; Spectrometry, X-Ray Emission; Tumor Cells, Cultured | 2013 |
Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents.
Topics: Amination; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzopyrans; Bromine; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Necrosis; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Transplantation, Heterologous | 2004 |